High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation.

CONCLUSIONS: Initial experience with transcatheter BF-VIV suggests that this method is feasible and that it improves aortic valve hemodynamics and clinical functional capacity. BF-VIV is a promising alternative to repeat surgery in patients with small failing bioprostheses. PMID: 28691908 [PubMed - as supplied by publisher]
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research